Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients with Hypertension-Reference-Cited by-同舟云学术

Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients with Hypertension

Published:2012-12 Issue:6 Volume:14 Page:401-409
ISSN:1174-5878
Container-title:Pediatric Drugs
language:en
Short-container-title:Pediatric Drugs

Author:

Wells Thomas G.,Blowey Douglas L.,Sullivan Janice E.,Blumer Jeffrey,Sherbotie Joseph R.,Song SaeHeum,Rohatagi Shashank,Heyrman Reinilde,Salazar Daniel E.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pediatrics, Perinatology and Child Health

Reference23 articles.

1. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

2. Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension

3. Cardiovascular Morbidity and Mortality in Hypertensive Patients With Lower Versus Higher Risk

4. Blood Pressure in Children With Chronic Kidney Disease

5. Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term pharmacotherapy of the primary hypertension in children;Pediatrie pro praxi;2021-11-24

2. Arterial Hypertension in Children;Handbook of Experimental Pharmacology;2020

3. Developmental Changes in Pharmacokinetics and Pharmacodynamics;The Journal of Clinical Pharmacology;2018-09-24

4. Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions;Biopharmaceutics & Drug Disposition;2017-02-06

5. Assessment of the Cardiovascular Risk of Olmesartan Medoxomil-Based Treatment: Meta-Analysis of Individual Patient Data;American Journal of Cardiovascular Drugs;2016-08-26